Stevenage Bioscience Catalyst and OneNucleus partner to bring this latest iteration of the BioWednesday.
Life science companies are increasingly adopting data engineering technologies (AI/ML) to accelerate drug discovery and development. Within this field, as technology leads to a growing volume of data, we are seeing the emergence of young AI start-ups, a lot of big deals between early-stage companies and larger pharma companies (who have access to increasing volumes of data) and service providers who are supporting pharma. Our BioWednesday Webinar will feature a panel of experienced entrepreneurs discussing the different ways that AI can be used to aid successful drug discovery and development, what is needed to optimize these various models/relationships and ultimately how can companies mature innovation in this space to create patient impact faster.
Panelists and agenda to be announced soon. SBC occupiers should email below to receive a free ticket for the event.
One Nucleus Members: Free
Non-Members: £50 +VAT
SBC Occupiers: Free, please contact email@example.com